Сравнение

Buserelin vs. Glepaglutide

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

57982-77-1

нет данных

Молекулярная масса

1239.42 g/mol

нет данных

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Buserelin

Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Glepaglutide

As a GLP-2 receptor agonist, glepaglutide has a trophic effect on the intestinal mucosa, enlarging the absorptive surface and thereby improving intestinal uptake of nutrients and fluid.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Buserelin	Glepaglutide
Германия	Рецептурный	Не одобрено
США	Не одобрено	Не одобрено

Полные записи

Frequently asked questions

What is the difference between Buserelin and Glepaglutide?: Buserelin is classified as "Исследования (прочее)", while Glepaglutide is classified as "Исследования (прочее)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Buserelin or Glepaglutide?: The highest available evidence level is "РКИ на людях" for Buserelin and "РКИ на людях" for Glepaglutide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Buserelin and Glepaglutide in Germany and the United States?: Германия: Buserelin — Рецептурный, Glepaglutide — Не одобрено. США: Buserelin — Не одобрено, Glepaglutide — Не одобрено. These are factual summaries with source and review date on the individual pages.

Country

Buserelin

Glepaglutide

Германия

Рецептурный

Не одобрено

США

Не одобрено

Frequently asked questions

What is the difference between Buserelin and Glepaglutide?

Buserelin is classified as "Исследования (прочее)", while Glepaglutide is classified as "Исследования (прочее)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Buserelin or Glepaglutide?

The highest available evidence level is "РКИ на людях" for Buserelin and "РКИ на людях" for Glepaglutide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Buserelin and Glepaglutide in Germany and the United States?

Германия: Buserelin — Рецептурный, Glepaglutide — Не одобрено. США: Buserelin — Не одобрено, Glepaglutide — Не одобрено. These are factual summaries with source and review date on the individual pages.